The efficacy and safety of bortezomib (velcade) in the treatment of relapsed multiple mye.
Warzocha
Krzysztof
K
Institute of Haematology and Blood Transfusion, 5 Chocimska Str., 00-957 Warsaw, Poland.
Kraj
Maria
M
Pogłód
Ryszard
R
Sokołowska
Urszula
U
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000633:toxicity; D001897:Boronic Acids / Q000008:administration & dosage / Q000633:toxicity*; D000069286:Bortezomib; D004341:Drug Evaluation; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D011719:Pyrazines / Q000008:administration & dosage / Q000633:toxicity*; D012008:Recurrence; D016879:Salvage Therapy / Q000379:methods; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib